Operationalizing Prescription Digital Therapeutics: Challenges and Solutions to Adoption

Pricing: Free for Members and $30 for Non-members 


Please note that this session is not accredited for continuing pharmacy education credit.

Course Description

PDTs carry several challenges when evaluating their application in payment models, some of which include: what changes need to be made to existing compendia and how will health outcomes be monitored? What needs to evolve between the patient and sponsor relationship to enable pharmacy reimbursement? Follow the journey from the diagnosis to patient access in this session that will describe the areas of success and opportunity related to PDTs. 

Target Audience

Pharmacists who practice in managed care settings.

Course summary
Course opens: 
Course expires: 


Edward Cox
General Manager & Head, Pfizer Digital Health & Medicines 
Pfizer, Inc. 

Ann Johnson, PharmD
Pharmacy Healthcare Solutions, LLC

Gail Ryan, PharmD
Senior Vice President, Specialty Pharmacy
Real Endpoints

Mahsa Salsabili, PharmD, PhD
Global Market Access Lead, CNS Digital Therapeutics 
Boehringer Ingelheim Pharmaceuticals, Inc. 

Scott Whittle, MD
Chief Medical Officer 
Meridian Outcomes 


Dan Leonard, MA
Granite Capitol Consulting

Please note that this session is not accredited for continuing pharmacy education credit.


Please login or register to take this course.

Required Hardware/software

System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities